Moderna Stock Jumps On Better-Than-Expected 2023 Sales menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
As of Jan. 8, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Moderna (NASDAQ: MRNA) saw its stock surge 13% after Oppenheimer & Co. (NYSE: OPY) analyst Hartaj Singh upgraded the stock to "outperform" and predicted five…
Oppenheimer & Co Analyst, Hartaj Singh, recently upgraded Moderna (MRNA) shares to "Outperform," with a price target of $142 per share. News of the upgrade…